Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.
2.

Impact of renal transplantation on cardiac morphological and functional characteristics in children and adults.

El-Khashab SO, Mohamed EE, Soliman MA, Kassem HH, Soliman AR.

World J Nephrol. 2016 Nov 6;5(6):517-523.

3.

Matrix Metalloproteinase (MMP)-9 Levels in Children on Hemodialysis: Association with MMP-9 C-1562T Gene Polymorphism and Vitamin D Levels.

Galal A, Fadel FI, Mokhtar E, Elshamaa MF, Elghoroury EA, Kamel S, Elsaeed GS, Thabet EH.

Int J Biomed Sci. 2016 Sep;12(3):95-104.

4.

Longitudinal assessment of cardiac morphology and function following kidney transplantation.

Kensinger C, Hernandez A, Bian A, Fairchild M, Chen G, Lipworth L, Ikizler TA, Birdwell KA.

Clin Transplant. 2017 Jan;31(1). doi: 10.1111/ctr.12864.

PMID:
27801526
5.

Lipid profile in pre-dialysis chronic kidney disease patients in southern Nigeria.

Adejumo OA, Okaka EI, Ojogwu LI.

Ghana Med J. 2016 Mar;50(1):44-9.

6.

Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.

Rutherford E, Talle MA, Mangion K, Bell E, Rauhalammi SM, Roditi G, McComb C, Radjenovic A, Welsh P, Woodward R, Struthers AD, Jardine AG, Patel RK, Berry C, Mark PB.

Kidney Int. 2016 Oct;90(4):845-52. doi: 10.1016/j.kint.2016.06.014.

7.

Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease.

Bhatti NK, Karimi Galougahi K, Paz Y, Nazif T, Moses JW, Leon MB, Stone GW, Kirtane AJ, Karmpaliotis D, Bokhari S, Hardy MA, Dube G, Mohan S, Ratner LE, Cohen DJ, Ali ZA.

J Am Heart Assoc. 2016 Aug 4;5(8). pii: e003648. doi: 10.1161/JAHA.116.003648. Review. No abstract available.

8.

Incidence of sudden cardiac death in adults with end-stage renal disease: a systematic review and meta-analysis.

Ramesh S, Zalucky A, Hemmelgarn BR, Roberts DJ, Ahmed SB, Wilton SB, Jun M.

BMC Nephrol. 2016 Jul 11;17(1):78. doi: 10.1186/s12882-016-0293-8.

9.

Design and methods of CYCLE-HD: improving cardiovascular health in patients with end stage renal disease using a structured programme of exercise: a randomised control trial.

Graham-Brown MP, March DS, Churchward DR, Young HM, Dungey M, Lloyd S, Brunskill NJ, Smith AC, McCann GP, Burton JO.

BMC Nephrol. 2016 Jul 8;17(1):69. doi: 10.1186/s12882-016-0294-7.

10.

Hyperphosphatemia Management in Patients with Chronic Kidney Disease.

Shaman AM, Kowalski SR.

Saudi Pharm J. 2016 Jul;24(4):494-505. doi: 10.1016/j.jsps.2015.01.009. Review.

11.

Cardiac Biomarkers and Left Ventricular Hypertrophy in Asymptomatic Hemodialysis Patients.

Koycheva RY, Cholakov V, Andreev J, Penev M, Iliev R, Nancheva K, Tsoneva V.

Open Access Maced J Med Sci. 2016 Mar 15;4(1):59-64. doi: 10.3889/oamjms.2016.011.

12.

Impaired longitudinal deformation measured by speckle-tracking echocardiography in children with end-stage renal disease.

van Huis M, Schoenmaker NJ, Groothoff JW, van der Lee JH, van Dyk M, Gewillig M, Koster L, Tanke R, Lilien M, Blom NA, Mertens L, Kuipers IM.

Pediatr Nephrol. 2016 Sep;31(9):1499-508. doi: 10.1007/s00467-016-3362-0.

13.

IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD.

Chen J, Kieswich JE, Chiazza F, Moyes AJ, Gobbetti T, Purvis GS, Salvatori DC, Patel NS, Perretti M, Hobbs AJ, Collino M, Yaqoob MM, Thiemermann C.

J Am Soc Nephrol. 2017 Jan;28(1):94-105. doi: 10.1681/ASN.2015060670.

PMID:
27153924
14.

Neutrophil to lymphocyte ratio might help prediction of acute myocardial infarction in patients with elevated serum creatinine.

Nalbant A, Cinemre H, Kaya T, Varim C, Varim P, Tamer A.

Pak J Med Sci. 2016 Jan-Feb;32(1):106-10. doi: 10.12669/pjms.321.8712.

15.

Echocardiography Criteria for Structural Heart Disease in Patients With End-Stage Renal Disease Initiating Hemodialysis.

Hickson LJ, Negrotto SM, Onuigbo M, Scott CG, Rule AD, Norby SM, Albright RC, Casey ET, Dillon JJ, Pellikka PA, Pislaru SV, Best PJ, Villarraga HR, Lin G, Williams AW, Nkomo VT.

J Am Coll Cardiol. 2016 Mar 15;67(10):1173-82. doi: 10.1016/j.jacc.2015.12.052.

PMID:
26965538
16.

Assessment of some cardiovascular risk factors in predialysis chronic kidney disease patients in Southern Nigeria.

Adejumo OA, Okaka EI, Madumezia G, Okwuonu CG, Ojogwu LI.

Niger Med J. 2015 Nov-Dec;56(6):394-9. doi: 10.4103/0300-1652.171616.

17.

Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study.

Gluba-Brzózka A, Michalska-Kasiczak M, Franczyk B, Nocuń M, Toth P, Banach M, Rysz J.

Lipids Health Dis. 2016 Feb 3;15:22. doi: 10.1186/s12944-016-0191-x. Erratum in: Lipids Health Dis. 2016;15(1):62.

18.

Connecting the dots on fibroblast growth factor 23 and left ventricular hypertrophy.

Gutiérrez OM.

Nephrol Dial Transplant. 2016 Jul;31(7):1031-3. doi: 10.1093/ndt/gfv445. No abstract available.

PMID:
26786549
19.

Risk factors for cardiovascular events among Asian patients without pre-existing cardiovascular disease on the renal transplant wait list.

Ningyan W, Chee Tang C, Ping Sing T, Lay Wai K, Koh AS, Shern KY, Terence, Chieh TW, Jack.

ASEAN Heart J. 2015;23(1):1.

20.

Association of Endothelial and Mild Renal Dysfunction With the Severity of Left Ventricular Hypertrophy in Hypertensive Patients.

Cao C, Hu JX, Dong YF, Zhan R, Li P, Su H, Peng Q, Wu T, Huang X, Sun WH, Wu QH, Cheng XS.

Am J Hypertens. 2016 Apr;29(4):501-8. doi: 10.1093/ajh/hpv128.

PMID:
26232035
Items per page

Supplemental Content

Support Center